Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.3 CHF | -0.75% | -3.73% | -5.30% |
04-25 | Transcript : Santhera Pharmaceuticals Holding AG, 2023 Earnings Call, Apr 25, 2024 | |
04-25 | Santhera Pharmaceuticals Swings to Profit in FY23; Revenue Grows | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-5.30% | 94.61M | |
+6.38% | 69.91B | |
+12.55% | 9.24B | |
-12.75% | 5.05B | |
+42.38% | 4.47B | |
+5.23% | 3.92B | |
+24.14% | 2.44B | |
-19.05% | 2.41B | |
-28.72% | 2.23B | |
+11.13% | 2.02B |
- Stock Market
- Equities
- SANN Stock
- News Santhera Pharmaceuticals Holding AG
- Santhera Pharmaceuticals' : Trial For Raxone Meets Primary Endpoint In Vision Loss Disease